Literature DB >> 19688785

Delivery of therapeutic RNAi by nanovehicles.

Huricha Baigude1, Tariq M Rana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19688785      PMCID： PMC3517099          DOI： 10.1002/cbic.200900252

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  41 in total

1.  Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery.

Authors:  P R Dash; M L Read; L B Barrett; M A Wolfert; L W Seymour
Journal:  Gene Ther       Date:  1999-04       Impact factor: 5.250

2.  Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.

Authors:  Ya-Lin Chiu; Akbar Ali; Chia-Ying Chu; Hong Cao; Tariq M Rana
Journal:  Chem Biol       Date:  2004-08

3.  Sensing the danger in RNA.

Authors:  Marjorie A Robbins; John J Rossi
Journal:  Nat Med       Date:  2005-03       Impact factor: 53.440

4.  RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.

Authors:  B Urban-Klein; S Werth; S Abuharbeid; F Czubayko; A Aigner
Journal:  Gene Ther       Date:  2005-03       Impact factor: 5.250

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 6.  Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation.

Authors:  B R Williams
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

7.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors.

Authors:  Erwei Song; Pengcheng Zhu; Sang-Kyung Lee; Dipanjan Chowdhury; Steven Kussman; Derek M Dykxhoorn; Yi Feng; Deborah Palliser; David B Weiner; Premlata Shankar; Wayne A Marasco; Judy Lieberman
Journal:  Nat Biotechnol       Date:  2005-05-22       Impact factor: 54.908

8.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.

Authors:  Raymond M Schiffelers; Aslam Ansari; Jun Xu; Qin Zhou; Qingquan Tang; Gert Storm; Grietje Molema; Patrick Y Lu; Puthupparampil V Scaria; Martin C Woodle
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

9.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

10.  Biochemical characterisation of polycation-induced cytotoxicity to human vascular endothelial cells.

Authors:  D M Morgan; V L Larvin; J D Pearson
Journal:  J Cell Sci       Date:  1989-11       Impact factor: 5.285
View more
  9 in total

1.  Double-stranded RNA Oral Delivery Methods to Induce RNA Interference in Phloem and Plant-sap-feeding Hemipteran Insects.

Authors:  Saikat Kumar B Ghosh; Wayne B Hunter; Alexis L Park; Dawn E Gundersen-Rindal
Journal:  J Vis Exp       Date:  2018-05-04       Impact factor: 1.355

Review 2.  Gene regulation by non-coding RNAs.

Authors:  Veena S Patil; Rui Zhou; Tariq M Rana
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-28       Impact factor: 8.250

3.  Interfering nanoparticles for silencing microRNAs.

Authors:  Huricha Baigude; Tariq M Rana
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

4.  Silencing microRNA by interfering nanoparticles in mice.

Authors:  Jie Su; Huricha Baigude; Joshua McCarroll; Tariq M Rana
Journal:  Nucleic Acids Res       Date:  2011-01-06       Impact factor: 16.971

Review 5.  Exosome mimetics: a novel class of drug delivery systems.

Authors:  Sander A A Kooijmans; Pieter Vader; Susan M van Dommelen; Wouter W van Solinge; Raymond M Schiffelers
Journal:  Int J Nanomedicine       Date:  2012-03-16

6.  Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.

Authors:  Joshua A McCarroll; Tanya Dwarte; Huricha Baigude; Jason Dang; Lu Yang; Rafael B Erlich; Kathleen Kimpton; Joann Teo; Sharon M Sagnella; Mia C Akerfeldt; Jie Liu; Phoebe A Phillips; Tariq M Rana; Maria Kavallaris
Journal:  Oncotarget       Date:  2015-05-20

7.  Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation.

Authors:  Zhihang Chen; Balaji Krishnamachary; Marie-France Penet; Zaver M Bhujwalla
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

Review 8.  Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer.

Authors:  Joshua McCarroll; Joann Teo; Cyrille Boyer; David Goldstein; Maria Kavallaris; Phoebe A Phillips
Journal:  Front Physiol       Date:  2014-01-24       Impact factor: 4.566

9.  Exosomes are natural carriers of exogenous siRNA to human cells in vitro.

Authors:  Tatyana A Shtam; Roman A Kovalev; Elena Yu Varfolomeeva; Evgeny M Makarov; Yury V Kil; Michael V Filatov
Journal:  Cell Commun Signal       Date:  2013-11-18       Impact factor: 5.712
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.